Following news of a global recall of batches of EpiPen, Mylan NV has also been hit with a class action lawsuit claiming the company struck a deal with pharmacy benefit managers (PBMs) over the price of the allergy treatment.

http://www.ajmc.com/newsroom/mylan-faces-product-recall-and-lawsuit-over-pbm-deal